This announcement is a separate document:
毕得医药：2024年度“提质增效重回报”行动方案的半年度评估报告
Bide Pharmaceutical: Semi-Annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Value Return” Action Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.